StockNews.AI
CHE
StockNews.AI
118 days

Chemed Reports First-Quarter 2025 Results

1. Chemed's Q1 2025 revenue rose 9% compared to last year. 2. VITAS Healthcare continues to strengthen its position in end-of-life care.

Earnings
-6.61%Current Return
VS
+2.13%S&P 500
$585.4604/23 04:23 PM EDTEvent Start
$546.7804/24 10:54 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

A 9% revenue increase indicates strong demand and effective management, similar to past growth trends in healthcare which have generally boosted stock prices.

How important is it?

Increased revenue and stable growth positions CHE favorably in the eyes of investors, enhancing its attractiveness as a reliable stock option.

Why Short Term?

The immediate financial results show positive performance, likely influencing short-term investor sentiment and price movements.

Related Companies

VTRSHCAUNH
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.

Related News